Literature DB >> 1372024

Characterization of proteoglycan-reactive T cell lines and hybridomas from mice with proteoglycan-induced arthritis.

J Y Leroux1, A R Poole, C Webber, V Vipparti, H U Choi, L C Rosenberg, S Banerjee.   

Abstract

Hyperimmunization with chondroitin sulfate-depleted fetal human cartilage proteoglycan (HFPG) leads to the development of peripheral arthritis and spondylitis in BALB/c mice. Chondroitin-sulfate-depleted adult human cartilage proteoglycan (HAPG) is much less effective at inducing arthritis. These observations suggest age differences in the presence of arthritogenic proteoglycan (PG) epitopes. Earlier studies from this laboratory have indicated an important role for PG-reactive T cells in the pathogenesis of this arthritis model. To investigate further the cellular immunity to PG in mice, two T cell lines, JY.A and JY.D, and two T cell hybridomas, TH5 and TH14, were isolated from mice with PG-induced arthritis and characterized. Two patterns of reactivity to PG emerged from the analysis of these T cells. One pattern, as demonstrated by the T cell line JY.D and the two T cell hybridomas, TH5 and TH14, was characterized by reactivity to HFPG, HAPG, chondroitin sulfate-depleted bovine cartilage PG, the G1 domain (hyaluronate binding region) of bovine cartilage PG and bovine link protein. The epitope(s) recognized by these T cells appear to be part of the homologous regions shared between the G1 domain and the link protein. The second pattern of reactivity, as demonstrated by the T cell line JY.A, was characterized by reactivity to HFPG but not to HAPG or the other PG Ag or bovine link protein. All the T cell lines and hybridomas had a CD4+, CD8- phenotype, possibly belonged to the TH1 subset (IL-2+, IL-4-), and were MHC class II restricted. These studies indicate that HFPG has T cell epitopes in common with HAPG (such as in the G1 domain) and different than those in HAPG. The significance of this data in terms of PG structure, changes with age, and induction of arthritis remains to be established.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372024

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Role of protein glycosylation in immune regulation.

Authors:  E F Hounsell; M J Davies
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

2.  Arthritis induced by proteoglycan aggrecan G1 domain in BALB/c mice. Evidence for t cell involvement and the immunosuppressive influence of keratan sulfate on recognition of t and b cell epitopes.

Authors:  Y Zhang; A Guerassimov; J Y Leroux; A Cartman; C Webber; R Lalic; E de Miguel; L C Rosenberg; A R Poole
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

3.  Aggrecan: A Target Molecule of Autoimmune Reactions.

Authors:  Edit I Buzás; Katalin Mikecz; Tibor T Glant
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

4.  Induction of arthritis in BALB/c mice by cartilage link protein: involvement of distinct regions recognized by T and B lymphocytes.

Authors:  Y Zhang; A Guerassimov; J Y Leroux; A Cartman; C Webber; R Lalic; E de Miguel; L C Rosenberg; A R Poole
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

5.  Human cartilage aggrecan CS1 region contains cryptic T-cell recognition sites.

Authors:  J A Goodacre; S Middleton; S Lynn; D A Ross; J Pearson
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

6.  Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo.

Authors:  J Y Leroux; A Guerassimov; A Cartman; N Delaunay; C Webber; L C Rosenberg; S Banerjee; A R Poole
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

7.  Cellular immunity to cartilage link protein in patients with inflammatory arthritis and non-arthritic controls.

Authors:  M C Doran; N J Goodstone; R N Hobbs; B A Ashton
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.